Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-21-000287
Filing Date
2021-01-12
Accepted
2021-01-12 17:23:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 50894
2 GRAPHIC g55959wh01.jpg GRAPHIC 4148
  Complete submission text file 0000950123-21-000287.txt   57648
Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701
Decibel Therapeutics, Inc. (Filer) CIK: 0001656536 (see all company filings)

EIN.: 464198709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations